TMS | Behavioral Treatment | Melville
TMS | Behavioral Treatment | Melville
To Schedule An Appointment
Tel: 631-270-4401 Suboxone :631-513-1672
TMS | Behavioral Treatment | Melville
 
Suboxone Therapy

Suboxone is the first opioid medication approved under DATA 2000 for the treatment of opioid dependence in an office base setting. The primary active ingredient in Suboxone is buprenorphine. Buprenorphine acts as an opioid agonist. What that means is that since Buprenorphine is an opioid itself it produces typical opioid effects such as euphoria thus allowing the opioid individual to discontinue their abuse of opioid(s) without experiencing withdrawal symptoms. The effects of buprenorphine increase as you increase its dose, however, after a point the effects reach a plateau and no longer intensify even if the dose is increased. Because of this quality, one is less likely to become addicted to buprenorphine.

There are three phases of Suboxone Maintenance Therapy:
  • The Induction Phase: An individual may be administered buprenorphine if the opioid-addicted individual has abstained from using opioids for 12-24 hour and is experiencing withdrawal symptoms. Induction is usually for observational purposes in the physician’s office.
  • The Stabilization Phase: This phase begins once a patient has greatly reduced or completely stopped using his or her opioid. And no longer has cravings for it.
  • The Maintenance Phase: This is the final phase of Suboxone therapy. The maintenance phase is reached when the patient is in compliance with a steady phase of buprenorphine.

Suboxone therapy is a great treatment option for opiate addiction because it reduces opioid cravings and withdrawal symptoms. It also causes less euphoria than full opioid agonists such as morphine and heroin, resulting in a lower potential for abuse and less physical dependence.

 

Connect With Us!

facebook
twitter
myspace
linkedin
 
NeuroStar TMS Therapy video
 
FAQ’s
 
 
Testimonials
Coming Soon











Coming Soon